Barely Significant
← all excerpts

Successful secukinumab treatment in focal segmental glomerulosclerosis associated with plaque psoriasis.

Ren Fail · 2022 · PMC9116267 · PMID 35546261

1
hedged sentence
closest p
boldest claim

The sentences

showed a trendno p-value reported
Our patient experienced no side effects from secukinumab treatment and showed a trend of improvement in proteinuria.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.